Integrative metabonomics as potential method for diagnosis of thyroid malignancy

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Tian, Yuan ^a   Nie, Xiu ^b   Xu, Shan ^a   Li, Yan ^b   Huang, Tao ^b   Tang, Huiru ^c   Wang, Yulan ^a,d  

^a Wuhan National Laboratory for Optoelectronics   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c FUDAN UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLCHOLINE;

BIOSYNTHESIS; DIFFERENTIAL DIAGNOSIS; GENETICS; GLYCOLYSIS; HUMAN; METABOLISM; METABOLOMICS; NEOPLASMS; NUCLEAR MAGNETIC RESONANCE; PATHOLOGY; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE;

DIAGNOSIS, DIFFERENTIAL; GLYCOLYSIS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; NEOPLASMS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHATIDYLCHOLINES; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE;

EID: 84944909219     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14869     Document Type: Article

References (60)

1. Lansford, C. D., Teknos, T. N. Evaluation of the thyroid nodule. Cancer control 13, 89-98 (2006).
2. Ghassi, D., Donato, A. Evaluation of the thyroid nodule. Postgrad. Med. J. 85, 190-195 (2009).
3. Siegel, R. L., Miller, K. D., Jemal, A. Cancer Statistics, 2015. Ca-Cancer. J. Clin. 65, 5-29 (2015).
4. Niedziela, M. Thyroid nodules. Best. Pract. Res. Cl. En. 28, 245-277 (2014).
5. Alexander, E. K. et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. New Engl. J. Med. 367, 705-715 (2012).
6. Torregrossa, L. et al. Toward the reliable diagnosis of indeterminate thyroid lesions: A HRMAS NMR-based metabolomics case of study. J. Proteome Res. 11, 3317-3325 (2012).
7. Tyler, D. S. et al. Thyroid cancer: 1999 Update. Ann. Surg. Oncol. 7, 376-398 (2000).
8. Castro, M. R., Gharib, H. Thyroid fine-needle aspiration biopsy: Progress, practice, and pitfalls. Endocr. pract. 9, 128-136 (2003).
9. Chow, L. S., Gharib, H., Goellner, J. R., van Heerden, J. A. Nondiagnostic thyroid fine-needle aspiration cytology: Management dilemmas. Thyroid 11, 1147-1151 (2001).
10. Saussez, S. et al. Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease. Thyroid 18, 705-712 (2008).
11. Carpi, A., Mechanick, J. I., Saussez, S., Nicolini, A. Thyroid tumor marker genomics and proteomics: Diagnostic and clinical implications. J. Cell. Physiol. 224, 612-619 (2010).
12. Costa Araujo, P. P. et al. mRNA BRAF expression helps to identify papillary thyroid carcinomas in thyroid nodules independently of the presence of BRAFV600E mutation. Pathol. Res. Pract. 208, 489-492 (2012).
13. Song, Q. et al. Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China. Diagn. Pathol. 6 (2011), doi: 10.1186/1746-1596-6-126.
14. Krause, K., Jessnitzer, B., Fuhrer, D. Proteomics in thyroid tumor research. J. Clin. Endocr. Metab. 94, 2717-2724 (2009).
15. Sofiadis, A. et al. Proteomic profiling of follicular and papillary thyroid tumors. Eur. J. Endocrinol. 166, 657-667 (2012).
16. Nicholson, J. K., Lindon, J. C. Systems biology-Metabonomics. Nature 455, 1054-1056 (2008).
17. Nicholson, J. K., Lindon, J. C., Holmes, E. 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181-1189 (1999).
18. Chan, E. C. Y. et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res. 8, 352-361 (2009).
19. Yang, Y. et al. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning H-1 NMR spectroscopy in conjunction with multivariate data analysis. J. Proteome Res. 6, 2605-2614 (2007).
20. Cheng, L. L. et al. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. P. Natl. Acad. Sci. USA 94, 6408-6413 (1997).
21. Yao, Z. et al. Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter. Mol. Biosyst. 7, 2608-2614 (2011).
22. Miccoli, P. et al. Metabolomics approach to thyroid nodules: A high-resolution magic-angle spinning nuclear magnetic resonancebased study. Surgery 152, 1118-1124 (2012).
23. Shi, X., Xiao, C., Wang, Y., Tang, H. Gallic acid intake induces alterations to systems metabolism in rats. J. Proteome Res. 12, 991-1006 (2013).
24. Jiang, L., Huang, J., Wang, Y., Tang, H. Metabonomic analysis reveals the CCl4-induced systems alterations for multiple rat organs. J. Proteome Res. 11, 3848-3859 (2012).
25. Weiss, R. E., Lado-Abeal, J. Thyroid nodules: Diagnosis and therapy. Curr. Opin. Oncol. 14, 46-52 (2002).
26. Castro, M. R., Gharib, H. Continuing controversies in the management of thyroid nodules. Ann. Intern. Med. 142, 926-931 (2005).
27. Sakorafas, G. H., Peros, G., Farley, D. R. Thyroid nodules: Does the suspicion for malignancy really justify the increased thyroidectomy rates? Surg. Oncol. 15, 43-55 (2006).
28. Eszlinger, M., Paschke, R. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol. Cell. Endocrinol. 322, 29-37 (2010).
29. Nikiforov, Y. E. et al. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer 120, 3627-3634 (2014).
30. Warburg, O. Orgin of cancer cells. Science 123, 309-314 (1956).
31. Tessem, M.-B. et al. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using H-1 HR-MAS spectroscopy of biopsy tissues. Magn. Reson. Med. 60, 510-516 (2008).
32. Selak, M. A. et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7, 77-85 (2005).
33. King, A., Selak, M. A., Gottlieb, E. Succinate dehydrogenase and fumarate hydratase: Linking mitochondrial dysfunction and cancer. Oncogene 25, 4675-4682 (2006).
34. Xiao, M. et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Gene. Dev. 26, 1326-1338 (2012).
35. Zhang, F., Du, G. Dysregulated lipid metabolism in cancer. World J. Biol. Chem. 3, 167-174 (2012).
36. Rysman, E. et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res. 70, 8117-8126 (2010).
37. Li, J., Cheng, J.-X. Direct visualization of de novo lipogenesis in single living cells. Sci. Rep.-UK 4 (2014), doi: 10.1038/srep06807.
38. Liu, Y. Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer P. D. 9, 230-234 (2006).
39. Nomura, D. K. et al. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140, 49-61 (2010).
40. Zeng, L. et al. Saturated fatty acids modulate cell response to DNA damage: Implication for their role in tumorigenesis. Plos One 3, e2329 (2008), doi: 10.1371/journal.pone.0002329.
41. He, C. et al. Inhibiting delta-6 desaturase activity suppresses tumor growth in mice. Plos One 7, e47567 (2012), doi: 10.1371/journal.pone.0047567.
42. Wang, D., Dubois, R. N. Eicosanoids and cancer. Nat. Rev. Cancer 10, 181-193 (2010).
43. Hagmuller, E., Kollmar, H. B., Gunther, H. J., Holm, E., Trede, M. Protein-metabolism in human colon carcinomas-in-vivo investigations using a modified tracer technique with L-1-C-13 leucine. Cancer Res. 55, 1160-1167 (1995).
44. Yao, K. S. et al. Evidence for altered regulation of gamma-glutamylcysteine synthetase gene-expression among cisplatin-sensitive and cisplatin-resistant human ovarian-cancer cell-lines Cancer Res. 55, 4367-4374 (1995).
45. Obrador, E. et al. Gamma-glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Hepatology 35, 74-81 (2002).
46. Ortega, A., Carretero, J., Obrador, E., Estrela, J. M. Tumoricidal activity of endothelium-derived NO and the survival of metastatic cells with high GSH and Bcl-2 levels. Nitric. Oxide-Biol. Ch. 19, 107-114 (2008).
47. Estrela, J. M., Ortega, A., Obrador, E. Glutathione in cancer biology and therapy. Crit. Rev. Cl. Lab. Sci. 43, 143-181 (2006).
48. Balendiran, G. K., Dabur, R., Fraser, D. The role of glutathione in cancer. Cell Biochem. Funct. 22, 343-352 (2004).
49. Tong, X., Zhao, F., Thompson, C. B. The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr. Opin. Genet. Dev. 19, 32-37 (2009).
50. Liu, Y.-C. et al. Global regulation of nucleotide biosynthetic genes by c-Myc. Plos One 3 (2008).
51. McLeod, H. L. et al. Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Brit. J. Cancer 77, 461-465 (1998).
52. Takechi, T., Okabe, H., Fujioka, A., Murakami, Y., Fukushima, M. Relationship between protein levels and gene expression of dihydropyrimidine dehydrogenase in human tumor cells during growth in culture and in nude mice. Jpn. J. Cancer Res. 89, 1144-1153 (1998).
53. Iorio, E. et al. Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res. 65, 9369-9376 (2005).
54. El-Sayed, S. et al. An ex vivo study exploring the diagnostic potential of H-1 magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head Neck-J. Sci. Spec. 24, 766-772 (2002).
55. Dai, H., Xiao, C., Liu, H., Tang, H. Combined NMR and LC-MS analysis reveals the metabonomic changes in Salvia miltiorrhiza Bunge induced by water depletion. J. Proteome Res. 9, 1460-1475 (2010).
56. Dai, H., Xiao, C., Liu, H., Hao, F., Tang, H. Combined NMR and LC-DAD-MS analysis reveals comprehensive metabonomic variations for three phenotypic cultivars of Salvia miltiorrhiza Bunge. J. Proteome Res. 9, 1565-1578 (2010).
57. Trygg, J., Wold, S. Orthogonal projections to latent structures (O-PLS). J. Chemometr. 16, 119-128 (2002).
58. Eriksson, L., Trygg, J., Wold, S. CV-ANOVA for significance testing of PLS and OPLS (R) models. J. Chemometr. 22, 594-600 (2008).
59. Cloarec, O. et al. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in H-1 NMR spectroscopic metabonomic studies. Anal. Chem. 77, 517-526 (2005).
60. An, Y. et al. High-fat diet induces dynamic metabolic alterations in multiple biological matrices of rats. J. Proteome Res. 12, 3755-3768 (2013).